Comparison of clinical outcomes between ticagrelor and clopidogrel in patients with acute coronary syndrome and left ventricle dysfunction undergoing percutaneous coronary intervention: An observational study.

We observed that the survival rate of the composite endpoint in the clopidogrel group was seemingly higher than in the ticagrelor group, although this difference did not reach statistical significance (HR = 1.68, 95% CI: 0.97–2.90, P = .065) (Fig. 2 A).

also in 111,027 other papers